Presentation Description: This session reviewed the development of strategies to identify patients at higher risk of having a recurrence of their leukemia. Contemporary criteria used in the Children’s Oncology Group trials for allocation to different risk groups for patients with acute lymphoblastic leukemia was reviewed. Modifications of therapy based on risk assignment were summarized.
Speaker: Sarah Alexander, MD
Clinical Director, Haematology/Oncology
Hospital for Sick Children, Toronto
Presentation Description: Do you show up at your screening appointments wondering why you’re even there? Or maybe you haven’t gone at all and are worried you missed the memo? Screening and prevention can be a tricky subject because there isn’t a ‘one size fits all’ standard. This presentation provides an overview of exactly what screening is, why it’s important, who is at risk for what, and what you need to know to responsibly manage your health for years to come.
Speaker: Paul Nathan, MD, MSc, FRCPC Director, AfterCare Program
Hospital for Sick Children
Presentation Description: Some survivors of childhood cancer may be at a higher risk for developing another cancer – but not all survivors are. This presentation explained what puts survivors at risk and provided strategies to decrease the risk.
Speaker: Mark Greenberg, OC, MB, ChB, FRCPC, FAAP
Senior Adviser, Policy & Clinical Affiars
Pediatric Oncology Group of Ontario (POGO), Toronto
Senior Staff Oncologist
Division of Haematology/Oncology, SickKids, Toronto
Professor of Paediatrics & Surgery, University of Toronto
Presentation Description: Survivors of childhood cancer are at increased risk of developing chronic medical conditions, primarily as a direct result of the treatments they received to cure their cancers (for example radiation, combination chemotherapy). Endocrine or hormone problems are among the most common chronic medical conditions seen in adult survivors of childhood cancer. Hormone problems are most often seen in persons who were treated with radiation to the brain, neck or pelvic area and those who received high doses of a class of chemotherapy drugs called alkylation agents (such as cyclophosphamide, busulfan, melphalan, thiotepa). Hormone problems can affect growth, sexual development, stamina, and overall well being. Fortunately, many hormone problems are treatable.
This presentation reviewed the major hormone complications seen in survivors of childhood cancer, risk factors for these problems, as well as common symptoms and treatment approaches.
Speaker: Mark Greenberg
Senior Adviser, Policy & Clinical Affiars
Pediatric Oncology Group of Ontario (POGO), Toronto
Senior Staff Oncologist
Division of Haematology/Oncology, SickKids, Toronto
Professor of Paediatrics & Surgery, University of Toronto
